We have some exciting news to share! The Motley Fool UK has now become The Twelfth Magpie -- an independent, UK-owned company, led by our long-serving UK management team — Mark Rogers, Chris Nials and Heather Adlington. In practical terms, it’s the same team you know, now fully focused on serving our UK readers and members.

Just as importantly, our approach remains unchanged: long-term, jargon-free, and on your side. This site is our new home, and there will be extra tweaks made across the coming few days as we settle in. So if anything looks a little off, please bear with us!

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

2 magnificent dividend stocks for recurrent income!

Identifying dividend stocks for passive income isn’t easy. There are many things to consider but our writer reckons she’s found two great options.

| More on:
Young mixed-race woman jumping for joy in a park with confetti falling around her

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Twelfth Magpie’s Premium Investing Services. Become a member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn more, and get a free 'Best Buy Now' stock!.

Two dividend stocks I think would be ideal for helping me build a second income stream are GSK (LSE: GSK) and Anglo American (LSE: AAL). Here’s why!

Essential healthcare

GSK is one of the biggest pharmaceutical businesses in the world with a mammoth footprint and a plethora of well-known products used everyday by millions of people.

Should you buy Anglo American Plc shares today?

Before you decide, please take a moment to review this report first. Despite ongoing uncertainties from US tariffs to global conflicts, Mark Rogers and his team believe many UK shares still trade at substantial discounts, offering savvy investors plenty of potential opportunities to learn about.

That’s why this could be an ideal time to secure this valuable research – Mark’s analysts have scoured the markets to reveal 5 of his favourite long-term ‘Buys’. Please, don’t make any big decisions before seeing them.

Due to macroeconomic and geopolitical volatility, GSK shares have meandered up and down in the past 12 months. However, they’re up 10% from 1,414p at this time last year, to current levels of 1,567p.

A big reason GSK is a great passive income stock for me is its defensive nature. Healthcare is essential for all no matter the economic outlook. This can span day-to-day drugs to more complex treatments for illnesses. This defensive ability allows the business to record stable earnings and reward investors.

Speaking of returns, a dividend yield of 4% is pretty attractive and it looks well covered by earnings, which is important. However, it’s worth remembering that dividends are never guaranteed. GSK also shares look excellent value for money right now on a price-to-earnings ratio of 10.

From a risk perspective, when pharma firms experience product issues, sentiment, performance, and returns can be impacted. GSK has had this before. It has faced lawsuits due to its discontinued Zantac heartburn drug.

Overall I’d be willing to buy GSK shares for my holdings the next time I have some investable cash.

Mining giant

Anglo American is one of the biggest mining businesses in the world and mines commodities including iron ore, copper, and nickel.

To say 2023 was a difficult year for Anglo American shares would be an understatement. The shares have fallen 47% over a 12-month period from 3,493p at this time last year to current levels of 1,849p.

Commodities are cyclical, which is a big risk. Production issues can hurt performance, returns, and sentiment. This has hurt Anglo in recent times as it has downgraded production forecasts.

However, I reckon the long-term outlook is favourable. Major initiatives in the future that will require huge quantities of the commodities that Anglo mines will boost the business, in my opinion. These include decarbonisation and infrastructure building. This is in line with the world’s growing population. For example, copper is essential in building infrastructure, as well as electricity grids for new and growing cities. This increased demand should help boost performance and returns.

Speaking of returns, an enticing dividend yield of 5.5% has been pushed up by the falling share price. However, the business has an excellent track record of investor returns and an attractive policy of returning 40% of underlying earnings to investors. I’m conscious that past performance is not a guarantee of the future and policies can change, as dividends are paid at the discretion of the business.

Anglo is another stock I’d be willing to buy when I next have some spare cash to invest. A mixed 2023 hasn’t fazed me. In fact, it’s thrown up an opportunity to buy cheaper shares now on a P/E ratio of 10, ahead of any rally and bull run.

Sumayya Mansoor has no position in any of the shares mentioned. The Motley Fool UK has recommended GSK. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Joyful mature couple having fun together enjoying vacation on city street. Two retired older people enjoying time together during autumn holidays or weekend getaway
Investing Articles

How much do you need in an ISA to target a £20,153 annual passive income on top of your State Pension?

Harvey Jones says the State Pension is nowhere near enough to fund a comfortable retirement, so you need to save…

Read more »

Smartly dressed middle-aged black gentleman working at his desk
Investing Articles

Near 5-year lows, here’s what the experts say about Greggs shares

Greggs’ shares went from a powerful growth story in 2024 to one of the FTSE 250’s worst-performing shares. Do experts…

Read more »

Investing Articles

How investing £20k in a Stocks and Shares ISA could generate a £15,815 yearly passive income for life

Harvey Jones shows how a single lump sum invested in a Stocks and Shares ISA can generate a high and…

Read more »

Investing Articles

Here are 3 cash-covered 7%-yielding FTSE 250 dividend shares with 30+ years of payouts

The FTSE 250 can be a minefield if you don't know what to look for. Mark Hartley breaks down his…

Read more »

Seniors having fun on bicycles in spring landscape
Investing Articles

With a 5.4% yield, 100 shares of this dividend stock could pay £250 of passive income

Our writer thinks this FTSE 250 bank stock still looks great value today, despite skyrocketing 303% over the past five…

Read more »

Landlady greets regular at real ale pub
Investing Articles

By mid-2027, analysts expect £10,000 in Diageo shares to be worth…

Diageo shares have tanked amid concerns over long-term demand for alcohol beverages. Is there the possibility of a rebound in…

Read more »

Wall Street sign in New York City
Investing Articles

UK investors are buying this stunning S&P 500 stock over Microsoft, Netflix and Nvidia. Why?

If you haven't heard of this S&P 500 growth stock yet, you soon will. British investors are keen but Harvey…

Read more »

Overjoyed exited middle aged married couple giving high five, finishing doing domestic paperwork together at home. Euphoric happy older mature spouses celebrating successful investment or purchase.
Investing Articles

How much do you need in an ISA to target a second income of £1,744 a month?

Harvey Jones shows how regular investing in FTSE 100 shares can build a generous second income for retirement, with minimum…

Read more »